George Kelly Martin - 10 Aug 2023 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ Sean Murphy, Attorney-in-Fact for George Kelly Martin
Issuer symbol
TLSI
Transactions as of
10 Aug 2023
Net transactions value
$0
Form type
4
Filing time
14 Aug 2023, 18:54:29 UTC
Next filing
21 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 10 Aug 2023 Common Stock 35,000 $11.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.